RNA G-quadruplexes in Neurodegeneration
Introduction
RNA G-quadruplexes (rG4s) are four-stranded nucleic acid structures formed by guanine-rich RNA sequences. These non-canonical structures play crucial roles in regulating post-transcriptional gene expression, including mRNA translation, splicing, and stability. In recent years, rG4 dysregulation has emerged as a significant contributor to neurodegenerative disease pathogenesis, particularly through effects on stress granule dynamics, phase separation, and protein aggregation[@brunk2024][@khaire2024].
The formation of rG4s involves the stacking of multiple G-quartets—planar arrangements of four guanines connected by Hoogsteen hydrogen bonds. These structures are stabilized by monovalent cations (particularly potassium) and can form in single-stranded RNA regions with runs of two or more consecutive guanines. The human genome contains thousands of potential rG4-forming sequences, many located in 5' UTRs, 3' UTRs, and intronic regions[@kwok2016].
Molecular Architecture
RNA G-quadruplexes differ from their DNA counterparts in several important ways:
Stability: RNA rG4s are generally more stable than DNA G4s due to the 2'-hydroxyl group of ribose, which contributes to more favorable stacking interactions
Topology: RNA rG4s typically adopt parallel conformations with all four strands running in the same direction
Flexibility: The presence of uracil in RNA provides additional hydrogen bonding potential that can influence structure
...RNA G-quadruplexes in Neurodegeneration
Introduction
RNA G-quadruplexes (rG4s) are four-stranded nucleic acid structures formed by guanine-rich RNA sequences. These non-canonical structures play crucial roles in regulating post-transcriptional gene expression, including mRNA translation, splicing, and stability. In recent years, rG4 dysregulation has emerged as a significant contributor to neurodegenerative disease pathogenesis, particularly through effects on stress granule dynamics, phase separation, and protein aggregation[@brunk2024][@khaire2024].
The formation of rG4s involves the stacking of multiple G-quartets—planar arrangements of four guanines connected by Hoogsteen hydrogen bonds. These structures are stabilized by monovalent cations (particularly potassium) and can form in single-stranded RNA regions with runs of two or more consecutive guanines. The human genome contains thousands of potential rG4-forming sequences, many located in 5' UTRs, 3' UTRs, and intronic regions[@kwok2016].
Molecular Architecture
RNA G-quadruplexes differ from their DNA counterparts in several important ways:
Stability: RNA rG4s are generally more stable than DNA G4s due to the 2'-hydroxyl group of ribose, which contributes to more favorable stacking interactions
Topology: RNA rG4s typically adopt parallel conformations with all four strands running in the same direction
Flexibility: The presence of uracil in RNA provides additional hydrogen bonding potential that can influence structureThe stability of rG4s is influenced by several factors:
- Sequence composition: The number and arrangement of G-tracts
- Loop length: Shorter loops generally increase stability
- Ion concentration: Potassium (K+) is the preferred stabilizing cation
- Molecular context: RNA-binding proteins can stabilize or destabilize rG4s
Detection Methods
Several experimental approaches exist for detecting rG4s in cells:
- Sequencing-based: G4-seq, rG4-seq, and related techniques
- Small molecule ligands: Fluorescent probes like Thioflavin T and Diamond Green
- Antibody-based: Specific antibodies that recognize rG4 structures
- Computational prediction: Algorithms like G4Hunter and G4RNA screener
Stress granules (SGs) are membrane-less organelles formed by liquid-liquid phase separation (LLPS) in response to cellular stress. They function to sequester translationally arrested mRNAs and associated proteins, protecting the cell during stress and facilitating recovery. rG4s play a critical role in SG formation through several mechanisms[@rampersaud2024][@fahour2024].
RNA molecules with rG4-forming sequences can undergo phase separation through multivalent interactions with RNA-binding proteins (RBPs). The negatively charged phosphate backbone of RNA interacts with positively charged domains in proteins like TIA-1, G3BP1, and TDP-43, driving condensation into SG-like structures.
Key proteins involved in rG4-mediated phase separation include:
- TIA-1: Contains RNA recognition motifs that bind rG4s
- G3BP1: A master regulator of SG assembly that interacts with structured RNAs
- TDP-43: An RNA-binding protein with G4-binding capacity implicated in ALS/FTD
Stress Granule Dysregulation in Disease
In neurodegenerative diseases, stress granule dynamics are frequently dysregulated:
Alzheimer's Disease: rG4s in tau and amyloid precursor protein (APP) mRNAs may contribute to aberrant SG formation
Parkinson's Disease: rG4s in alpha-synuclein (SNCA) mRNA influence protein translation and aggregation
ALS/FTD: Mutations in genes like C9orf72 produce rG4-forming sequences that form toxic RNA foci and drive SG pathologyRNA G-quadruplexes in Protein Aggregation
Alpha-Synuclein and Parkinson's Disease
The SNCA gene, encoding [alpha-synuclein](/proteins/alpha-synuclein), contains multiple rG4-forming sequences in its 5' UTR and coding region. These rG4s can:
Increase translation: rG4s in the 5' UTR can enhance mRNA translation efficiency
Promote aggregation: rG4-binding proteins may facilitate co-localization with alpha-synuclein
Form RNA-protein complexes: rG4s can nucleate phase-separated droplets containing alpha-synucleinStudies have shown that stabilizing rG4s in the SNCA mRNA increases protein expression, while rG4 destabilization reduces aggregation propensity[@western2019][@wang2022].
Tau and Alzheimer's Disease
The MAPT gene (encoding [tau protein](/proteins/tau)) also contains rG4-forming sequences. rG4-binding proteins like nucleolin have been implicated in regulating tau expression[@simone2019]. Dysregulated rG4 metabolism may contribute to:
- Aberrant tau translation and aggregation
- Formation of tau-containing stress granules
- Sequestration of RNA-binding proteins in tau pathology
TDP-43 and ALS/FTD
[TDP-43](/proteins/tdp-43-protein) is an RNA-binding protein that forms cytoplasmic inclusions in ALS and FTD. The protein can bind to rG4 structures, and this interaction may contribute to pathological aggregation[@conlon2018][@morelli2021]:
rG4 binding may alter TDP-43 phase separation behavior
TDP-43 pathology may disrupt normal rG4 metabolism
rG4-stabilizing small molecules may reduce TDP-43 aggregation[FUS](/proteins/fus-protein) is another RNA-binding protein implicated in ALS that interacts with rG4 structures. The protein's prion-like domain facilitates liquid-liquid phase separation, and rG4-containing RNAs may influence this process.
Therapeutic Targeting of RNA G-quadruplexes
Small Molecule Ligands
Several classes of rG4-binding small molecules are being developed for neurodegenerative disease therapy[@bufenoh2023][@chen2023]:
Pyridine derivatives: Cationic porphyrins and bipyridyl compounds
Acridine analogs: Compounds like acridine-4-carboxamide
Bisquinoline derivatives: Selectively stabilize rG4s over DNA G4s
Nucleic acid analogs: G-rich oligonucleotides that act as decoysTargeting Specific Disease Mechanisms
- PD: rG4 ligands targeting SNCA mRNA to reduce alpha-synuclein translation
- AD: Modulation of MAPT and APP rG4s to influence tau and Aβ pathology
- ALS/FTD: Interventions to normalize stress granule dynamics and TDP-43 pathology
Challenges and Opportunities
Key challenges in developing rG4-targeted therapeutics include:
Selectivity: Achieving specificity for disease-relevant rG4s
Brain penetration: Ensuring adequate distribution to the CNS
Target engagement: Verifying that small molecules reach their intended RNA targets
Safety: Avoiding disruption of essential rG4 functions in normal cellsMermaid Diagram: rG4 in Neurodegeneration Pathways
Mermaid diagram (expand to render)
Cross-Links to Related Pages
- [Alpha-Synuclein](/proteins/alpha-synuclein) - Parkinson's disease protein with rG4 regulation
- [Tau Protein](/proteins/tau) - Alzheimer's disease protein regulated by rG4s
- [TDP-43 Protein](/proteins/tdp-43-protein) - ALS/FTD protein with rG4 interactions
- [FUS Protein](/proteins/fus-protein) - ALS-associated RNA-binding protein
- [Stress Granules in Neurodegeneration](/mechanisms/stress-granules-in-neurodegeneration) - rG4-mediated SG dynamics
- [Phase Separation in Neurodegeneration](/mechanisms/phase-separation-neurodegeneration) - LLPS mechanisms
- [Parkinson's Disease](/diseases/parkinson-disease) - rG4 in alpha-synuclein pathology
- [Alzheimer's Disease](/diseases/alzheimers-disease) - rG4 in tau and APP metabolism
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) - rG4 in TDP-43 pathology
- [Frontotemporal Dementia](/diseases/frontotemporal-dementia) - rG4 and stress granule dysregulation
Conclusion
RNA G-quadruplexes represent an emerging frontier in understanding the molecular mechanisms of neurodegenerative diseases. Through their roles in stress granule formation, phase separation, and protein aggregation, rG4s provide a mechanistic link between RNA metabolism and the proteinopathies that characterize AD, PD, ALS, and related disorders. Targeting rG4 dynamics with small molecule ligands or RNA-based therapeutics offers a promising avenue for disease-modifying treatments, though significant challenges remain in achieving brain-penetrant, selective, and safe interventions.
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinson-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Stress Granules in Neurodegeneration](/mechanisms/stress-granules-in-neurodegeneration)
External Links
- [PubMed - RNA G-quadruplex and neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/)
- [G-quadruplex database](https://quadruplex.org/)